The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The results of a randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in uveal melanoma patients with hepatic metastasis.
D. J. Eschelman
No relevant relationships to disclose
C. F. Gonsalves
No relevant relationships to disclose
M. Terai
No relevant relationships to disclose
M. Laudadio
No relevant relationships to disclose
K. L. Sullivan
No relevant relationships to disclose
M. J. Mastrangelo
No relevant relationships to disclose
T. Sato
No relevant relationships to disclose